NewsNovo
A securities law firm has trained its sights on Medline Industries, Inc. (NASDAQ: MDLN), announcing an investigation into potential claims on behalf of the company's investors.
Pomerantz LLP disclosed the probe on July 9, 2026, though the firm did not specify what underlying conduct or disclosures prompted the review.
What Pomerantz is doing The announcement directed investors to contact Danielle Peyton at the firm. Two contact points were listed: newaction@pomlaw.com and 646-581-9980, extension 7980.
Beyond identifying MDLN and its investors as the subject of the inquiry, the notice contained no allegations, no named class period, and no identified financial harm. This is typical at an early stage.
Keep reading